Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas.

Related Articles

Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas.

Oncotarget. 2017 May 03;:

Authors: Hsieh KL, Chen CY, Lo CM

Abstract
The present study proposed a computer-aided diagnosis system based on radiomic features extracted through magnetic resonance imaging to determine the isocitrate dehydrogenase status in glioblastomas. Magnetic resonance imaging data were obtained from 32 patients with wild-typeisocitrate dehydrogenase and 7 patients with mutant isocitrate dehydrogenase in glioblastomas. Radiomic features, namely morphological, intensity, and textural features, were extracted from the tumor area of each patient. The feature sets were evaluated using a logistic regression classifier to develop a prediction model. The accuracy of the global morphological and intensity features was 51% (20/39) and 59% (23/39), respectively. The textural features describing local patterns yielded an accuracy of 85% (33/39), which is significantly higher than that yielded by the morphological and intensity features. The agreement level (κ) between the prediction results and biopsy-proven pathology was 0.60. The proposed diagnosis system based on radiomic textural features shows promise for application in providing suggestions to radiologists for distinguishing isocitrate dehydrogenase mutations in glioblastomas.

PMID: 28526813 [PubMed - as supplied by publisher]

http://ift.tt/2q64Ptz